Are you Dr. Hoang?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 30 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
600 Highland Ave
Madison, WI 53792Phone+1 608-265-1700Fax+1 608-265-8133
Summary
- Dr. Tien Hoang, MD is an oncologist in Madison, Wisconsin. He is currently licensed to practice medicine in Wisconsin. He is an Assistant Professor at University of Wisconsin School of Medicine & Public Health.
Education & Training
SUNY Downstate Health Sciences UniversityFellowship, Hematology and Medical Oncology, 1998 - 2001
BronxCare Health SystemResidency, Internal Medicine, 1995 - 1998
Ho Chi Minh City Medicine and Pharmacy UniversityClass of 1987
Certifications & Licensure
WI State Medical License 2001 - 2023
Awards, Honors, & Recognition
- Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2012
Clinical Trials
- S0220: Chemoradiotherapy Followed By Surgery and Docetaxel in Treating Patients With Pancoast Tumors Start of enrollment: 2003 Jul 01
- Vorinostat and Bortezomib as Third-line Treatment in Advanced Non-small Cell Lung Cancer Start of enrollment: 2008 Dec 01
- Trial of ZD6474 and Faslodex in Non-Small Cell Lung Cancer Start of enrollment: 2009 Nov 01
Publications & Presentations
PubMed
- 24 citationsA phase I study of vorinostat in combination with bortezomib in patients with advanced malignanciesWilliam R. Schelman, Anne M. Traynor, Kyle D. Holen, Jill M. Kolesar, Steven Attia
Investigational New Drugs. 2013-10-10 - 45 citationsPhase II study of second-line gemcitabine in sensitive or refractory small cell lung cancer.Tien Hoang, KyungMann Kim, Anthony Jaslowski, Paul L. Koch, Peter A. Beatty
Lung Cancer. 2003-10-01 - 75 citationsPilot study of gefitinib and fulvestrant in the treatment of post-menopausal women with advanced non-small cell lung cancerAnne M. Traynor, Joan H. Schiller, Laura P. Stabile, Jill M. Kolesar, Jens C. Eickhoff
Lung Cancer. 2009-04-01
